These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 17039505

  • 1. Randomized trial versus registry data--comparing apples and ORCHIDs.
    Moliterno DJ.
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):669-70. PubMed ID: 17039505
    [No Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of drug-eluting stents.
    Williams DO, Kereiakes DJ.
    Rev Cardiovasc Med; 2005 Nov; 6 Suppl 1():S22-30. PubMed ID: 15665794
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of BMS in the drug eluting stent era: is still there any place for them?
    Fineschi M, Gori T.
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):456; author reply 457. PubMed ID: 16892446
    [No Abstract] [Full Text] [Related]

  • 6. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
    Perin EC.
    Rev Cardiovasc Med; 2005 Sep; 6 Suppl 1():S13-21. PubMed ID: 15665793
    [Abstract] [Full Text] [Related]

  • 7. Drug-eluting stents: the panacea for restenosis?
    Lim MC.
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lessons from the E-SIRIUS trial.
    Schofer J.
    Ital Heart J; 2004 Jan; 5(1):1-2. PubMed ID: 15080572
    [No Abstract] [Full Text] [Related]

  • 10. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A, Brodsky A, Sabapathy R, Pershad A.
    Indian Heart J; 2008 Jan; 60(3):195-9. PubMed ID: 19240306
    [Abstract] [Full Text] [Related]

  • 11. Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease).
    Colombo A, Chieffo A.
    Circulation; 2007 Sep 18; 116(12):1424-32. PubMed ID: 17875983
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug-eluting stents: preventing restenosis.
    Slavin L, Chhabra A, Tobis JM.
    Cardiol Rev; 2007 Sep 18; 15(1):1-12. PubMed ID: 17172878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modern strategies to prevent coronary restenosis.
    Chieffo A, Stankovic G, Colombo A.
    Ital Heart J; 2002 Jun 18; 3 Suppl 4():9S-15S. PubMed ID: 12116826
    [No Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, Ussia GP, Tamburino C.
    Catheter Cardiovasc Interv; 2007 Jun 01; 69(7):976-83. PubMed ID: 17295334
    [Abstract] [Full Text] [Related]

  • 19. Polymer-based paclitaxel-eluting stents implantation in unprotected left main.
    Colombo A.
    Catheter Cardiovasc Interv; 2007 Feb 15; 69(3):378-9. PubMed ID: 17295282
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.